REGENICELL Trademark

Trademark Overview

On Thursday, May 12, 2011, a trademark application was filed for REGENICELL with the United States Patent and Trademark Office. The USPTO has given the REGENICELL trademark a serial number of 85319291. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 5, 2015. This trademark is owned by Garnet BioTherapeutics, Inc.. The REGENICELL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of dermatological, orthopedic, neurological, cardiovascular, ophthalmic and immune disorders and diseases; pharmaceuticals for use in the treatment of scarring
regenicell

General Information

Serial Number85319291
Word MarkREGENICELL
Filing DateThursday, May 12, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 5, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2011

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of dermatological, orthopedic, neurological, cardiovascular, ophthalmic and immune disorders and diseases; pharmaceuticals for use in the treatment of scarring

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGarnet BioTherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
Party NameGarnet BioTherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Monday, January 5, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 5, 2015ABANDONMENT - NO USE STATEMENT FILED
Friday, May 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 15, 2014EXTENSION 5 GRANTED
Tuesday, May 13, 2014EXTENSION 5 FILED
Tuesday, May 13, 2014TEAS EXTENSION RECEIVED
Thursday, December 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2013EXTENSION 4 GRANTED
Wednesday, November 27, 2013EXTENSION 4 FILED
Wednesday, November 27, 2013TEAS EXTENSION RECEIVED
Wednesday, November 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2013EXTENSION 3 GRANTED
Tuesday, May 28, 2013EXTENSION 3 FILED
Friday, June 21, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 28, 2013TEAS EXTENSION RECEIVED
Friday, October 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 18, 2012EXTENSION 2 GRANTED
Tuesday, October 16, 2012EXTENSION 2 FILED
Wednesday, October 17, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 16, 2012TEAS EXTENSION RECEIVED
Friday, May 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 23, 2012EXTENSION 1 GRANTED
Wednesday, May 23, 2012EXTENSION 1 FILED
Wednesday, May 23, 2012TEAS EXTENSION RECEIVED
Tuesday, November 29, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011PUBLISHED FOR OPPOSITION
Monday, August 29, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 29, 2011ASSIGNED TO EXAMINER
Tuesday, May 17, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 16, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

regenicell pharmaceuticals treatment disorders scarring immune diseases cardiovascular dermatological orthopedic neurological